Skip links
Companies
› United States › CITIUS PHARMACEUTICALS, INC.
CITIUS PHARMACEUTICALS, INC. logo

CITIUS PHARMACEUTICALS, INC.

Active

in

Registration No.
0101041352
Incorporation Date
2016-06-13
Company Type
Not disclosed
Address
Cranford, United States
Website
citiuspharma.com/
Source: New Jersey Division of Revenue & Enterprise Services

CITIUS PHARMACEUTICALS, INC. is a registered legal entity registered in United States under 0101041352, and its current status with New Jersey Division of Revenue & Enterprise Services is active. The company was incorporated on 13 June 2016 and lists its registered address as Cranford, United States. 2 shareholders are on record for CITIUS PHARMACEUTICALS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from New Jersey Division of Revenue & Enterprise Services and was last updated on 5 October 2026.

Data Provenance
This record is sourced directly from official government registries, including New Jersey Division of Revenue & Enterprise Services.

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

2

Two shareholders are currently on record for CITIUS PHARMACEUTICALS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.

The largest of these is Vanguard Group Inc, holding 23.9% — the largest recorded stake — followed by UBS Group AG at 9.2%.

Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Shareholder Type Holding Source Document
Vanguard Group Inc 23.9% New Jersey Division of Revenue & Enterprise Services
UBS Group AG 9.2% New Jersey Division of Revenue & Enterprise Services

View all shareholders & beneficial ownership
Full cap table, ownership percentages, and ultimate beneficial owners resolved down to the natural person.

View all shareholders →

Officers

5

The Chief Business Officer & Cfo of CITIUS PHARMACEUTICALS, INC. currently on record is Jaime Bartushak; five officers are currently on record for CITIUS PHARMACEUTICALS, INC., filed with New Jersey Division of Revenue & Enterprise Services.

The register reports 10 officers in total, including past appointments, though only the 5 most relevant records are shown here.

Management authority at CITIUS PHARMACEUTICALS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

JB
Jaime Bartushak ACTIVE

Appointed
2016-01-01
Residence
🇺🇸 United States
Occupation
Chief Business Officer & Cfo

IA
Ilanit Allen ACTIVE

Residence
🇺🇸 United States
Occupation
Vice President Of Investor Relations & Corporate Communications

MS
Myron S. Czuczman M.d. ACTIVE

Residence
🇺🇸 United States
Occupation
Executive Vp & Chief Medical Officer

NB
Nikolas Burlew ACTIVE

Residence
🇺🇸 United States
Occupation
Executive Vice President Of Quality Assurance

DG
Dhananjay G. Wadekar ACTIVE

Residence
🇺🇸 United States
Occupation
Senior Vice President Of Business Strategy

View all officers & directors
Complete appointment history, representation authority, and officer-level filings across jurisdictions.

View all officers →

Group Structure

CITIUS PHARMACEUTICALS, INC. has no recorded parent company — it sits at the top of its own group structure, with 4 subsidiaries recorded beneath it across 1 jurisdiction. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.

Those 4 subsidiaries span United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.

Ultimate HQ
CITIUS PHARMACEUTICALS, INC.
United States
Novecite, Inc.
United StatesUS NJ 3435411

CITIUS PHARMACEUTICALS, LLC
United StatesUS MA 000942709

Leonard-Meron Biosciences, Inc.
United StatesUS NJ 5307312

Citius Oncology, Inc.
United StatesUS NJ 4566646

Explore the full group structure
Map the complete corporate hierarchy: parent companies, subsidiaries, and cross-border ownership chains.

View full group structure →

Need the full UBO picture on CITIUS PHARMACEUTICALS, INC.?

Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.

Frequently Asked Questions

Who owns CITIUS PHARMACEUTICALS, INC.?

Two shareholders are currently on record for CITIUS PHARMACEUTICALS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 23.9% — the largest recorded stake — followed by UBS Group AG at 9.2%. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is CITIUS PHARMACEUTICALS, INC.'s UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for CITIUS PHARMACEUTICALS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does CITIUS PHARMACEUTICALS, INC. have on record?

2 shareholders are shown on record for CITIUS PHARMACEUTICALS, INC..

What is CITIUS PHARMACEUTICALS, INC.'s company registration number?

CITIUS PHARMACEUTICALS, INC.'s registration number is 0101041352, filed with New Jersey Division of Revenue & Enterprise Services in United States. Its current status on the register is active.

Is CITIUS PHARMACEUTICALS, INC. still an active company?

CITIUS PHARMACEUTICALS, INC.'s status on New Jersey Division of Revenue & Enterprise Services is listed as active.

When was CITIUS PHARMACEUTICALS, INC. incorporated?

CITIUS PHARMACEUTICALS, INC. was incorporated on 13 June 2016, according to New Jersey Division of Revenue & Enterprise Services.

What is CITIUS PHARMACEUTICALS, INC.'s registered address?

The registered address on file for CITIUS PHARMACEUTICALS, INC. is Cranford, United States.

Who are the officers/directors of CITIUS PHARMACEUTICALS, INC.?

The Chief Business Officer & Cfo of CITIUS PHARMACEUTICALS, INC. currently on record is Jaime Bartushak; five officers are currently on record for CITIUS PHARMACEUTICALS, INC., filed with New Jersey Division of Revenue & Enterprise Services. Management authority at CITIUS PHARMACEUTICALS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Does CITIUS PHARMACEUTICALS, INC. have a parent company or subsidiaries?

CITIUS PHARMACEUTICALS, INC. has no recorded parent company — it sits at the top of its own group structure, with 4 subsidiaries recorded beneath it across 1 jurisdiction. Those 4 subsidiaries span United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.

Can Zavia monitor changes to CITIUS PHARMACEUTICALS, INC.'s ownership over time?

This profile reflects a point-in-time snapshot from New Jersey Division of Revenue & Enterprise Services. Zavia's monitoring API can track changes to CITIUS PHARMACEUTICALS, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.

Can I access CITIUS PHARMACEUTICALS, INC.'s data through an API?

Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like CITIUS PHARMACEUTICALS, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.

Where does this company information come from, and how current is it?

This record is sourced directly from New Jersey Division of Revenue & Enterprise Services and was last synced on 5 October 2026.

This website uses cookies to improve your web experience.